Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Concurrent Session 1: Aneuploidy as a Driver of Cancer Evolution

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Concurrent Session 1: Aneuploidy as a Driver of Cancer Evolution
Job's dilemma for the genome: Why bad things happen to good chromosomes
David Pellman
Dana-Farber Cancer Institute, Boston, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 4:30 PM-6:00 PM
Concurrent Session 1: Aneuploidy as a Driver of Cancer Evolution
Chromosomal instability as a driver of tumor metastasis
Samuel F Bakhoum
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 4:30 PM-6:00 PM
Concurrent Session 1: Aneuploidy as a Driver of Cancer Evolution
Mechanisms of aneuploidy-driven tumorigenesis
Stephen J. Elledge
Harvard Medical School, Boston, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 4:30 PM-6:00 PM
Concurrent Session 1: Aneuploidy as a Driver of Cancer Evolution
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures
Thomas G. Graeber
UCLA, Los Angeles, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 28, 2017 4:30 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4